Uterine perforation caused by intrauterine devices: Clinical course and treatment

Human Reproduction

Volumn 28, Issue 6, 2013, Pages 1546-1551

  Kaislasuo, Janina ^a   Suhonen, Satu ^b   Gissler, Mika ^c,d   Lähteenmäki, Pekka ^a   Heikinheimo, Oskari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b City of Helsinki   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

Author keywords

clinical course; IUD; IUS; perforation

Indexed keywords

CONTRACEPTIVE AGENT; COPPER INTRAUTERINE DEVICE; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; UNCLASSIFIED DRUG;

ABDOMINAL INFECTION; ABDOMINAL PAIN; ABDOMINAL SURGERY; ADULT; ARTICLE; BLEEDING; CURETTAGE; DEVICE REMOVAL; FEMALE; HUMAN; HYSTEROSCOPY; INTRAUTERINE CONTRACEPTIVE DEVICE; LAPAROSCOPY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PERITONEUM ADHESION; PREGNANCY; TRANSVAGINAL ECHOGRAPHY; UTERUS PERFORATION; X RAY; AGED; MIDDLE AGED; RETROSPECTIVE STUDY; UTERINE PERFORATION;

ADULT; AGED; FEMALE; HUMANS; INTRAUTERINE DEVICES; MIDDLE AGED; RETROSPECTIVE STUDIES; UTERINE PERFORATION;

EID: 84878331456     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/det074     Document Type: Article

References (25)

1. Adoni A, Ben Chetrit A. The management of intrauterine devices following uterine perforation. Contraception 1991;43:77-81.
2. Andersson K, Mattson LK, Rybo G, Stadberg E. Intrauterine release of levonorgestrel-a new way of adding progestogen in hormone replacement therapy. Obstet Gynecol 1992;79:963-967.
3. Andersson K, Ryde-Blomqvist E, Lindell K, Odlind V, Milsom I. Perforations with intrauterine devices. Contraception 1998;57:251-255.
4. Boortz HE, Margolis DJA, Ragavendra N, Patel MK, Kadell BM. Migration of intrauterine devices: radiologic findings and implications for patients care. Radiographics 2012;32:335-352.
5. Brokelman W, Lensvelt M, Rinkel I, Klinkenbijl J, Rejnen M. Peritoneal changes due to laparoscopic surgery. Surg Endosc 2011;25:1-9.
6. Caliskan E, Öztürk N, Dilbaz Ö, Dilbaz S. Analysis of risk factors associated with uterine perforation by intrauterine devices. Eur J Contracept Reprod Health Care 2003;8:150-155.
7. Gill R, Mok D, Hudson M, Shi X, Birch D, Karmal S. Laparoscopic removal of an intra-abdominal intrauterine device: case and systematic review. Contraception 2012;85:15-18.
8. Haimov-Kohman R, Amsalem H, Adoni A, Lavy Y, Spitz I. Management of a perforated levonorgestrel-medicated intrauterine device-a pharmacokinetic study: case report. Hum Reprod 2003a;18:1231-1233.
9. Haimov-Kohman R, Doviner V, Amsalem H, Prus D, Adoni A, Lavy Y. Intraperitoneal levonorgestrel-releasing intrauterine device following uterine perforation: the role of progestins in adhesion formation. Hum Reprod 2003b;18:990-993.
10. Heikinheimo O, Gemzell-Daniselsson K. Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS). Acta Obstet Gynecol Scand 2012;91:3-9.
11. Heinemann K, Barnett C, Dinger J. Risk Factors for Uterine Perforations during IUD Insertion: Interim Results from the EURAS-IUD Study 2011. http://www.pharmacoepi.org/meetings/27thconf/presentations/ Risk%20Factors%20for%20Uterine%20Perforations%20during%20IUD% 20Insertion-%20Interim%20Results%20from%20the%20EURAS-IUD% 20Study.pdf (29 January 2013, date last accessed).
12. International Classification of Diseases (ICD). World Health Organization (WHO) 2010: http://apps.who.int/classifications/icd10/browse/2010/en (29 January 2013, date last accessed).
13. Kaislasuo J, Suhonen S, Gissler M, Lähteenmäki P, Heikinheimo O. Intrauterine contraception: incidence and factors associated with uterine perforation-a population-based study. Hum Reprod 2012; 27:2658-2663.
14. Lewis R, Taylor D, Natavio M, Melamed A, Felix J, Mishell D Jr. Effects of the levonorgestrel-releasing intrauterine system on cervical mucus quality and sperm penetrability. Contraception 2010;82:491-496.
15. Luukkainen T, Pakarinen P, Toivonen J. Progestin-releasing intrauterine systems. Semin Reprod Med 2001;19:355-363.
16. Markovitch O, Klein Z, Gidoni Y, Holzinger M, Beyth Y. Extrauterine mislocated IUD: is surgical removal mandatory? Contraception 2002; 66:105-108.
17. Milsom I. The levonorgestrel-releasing intrauterine system as an alternative to hysterectomy in peri-menopausal women. Contraception 2007; 75:152-154.
18. Nilsson CG, Lähteenmäki P, Luukkainen T, Robertson D. Sustained intrauterine release of levonorgestrel over five years. Fertil Steril 1986; 33:139-148.
19. Nordic Medico-Statistical Committee (NOMESCO). Classification of Surgical Procedures. Version 1.15 2011 no. 93:2010 Copenhagen, 2010.
20. Olivieira da Silva M, Jahn A, Olsen J, Karro H, Temmerman M, Gissler M, Bloemenkamp K, Fronteira I. The Reproductive Health Report-the state of sexual and reproductive health within the European Union. Eur J Contracept Reprod Health Care 2011;16(S1):S1-S70.
21. Ortiz M, Croxatto H. Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action. Contraception 2007;75:16-30.
22. van Grootheest K, Sachs B, Harrison-Woolrych M, Caduff-Janosa P, van Puijenbroek E. Uterine perforation with the levonorgestrel-releasing intrauterine device: analysis of reports from four national pharmacovigilance centres. Drug Saf 2011;34:83-88.
23. van Haudenhoven K, van Kaam KJAF, van Grootheest AC, Salemans THB, Dunselman GAJ. Uterine perforation in women using a levonorgestrel-releasing intrauterine system. Contraception 2006;73:257-260.
24. World Population Bureau. Family Planning Worldwide, 2008 Data Sheet. http://www.prb.org/pdf08/fpds08.pdf (29 January 2013, date last accessed).
25. Zakin D, Stern WZ, Rosenblatt R. Complete and partial uterine perforation and embedding following insertion of intrauterine devices I. Classification, complications, mechanism, incidence and missing strings. Obstet Gynecol Surv 1981;36:335-353.